Commitments and Contingencies (Details) |
3 Months Ended |
|---|---|
Mar. 31, 2023 | |
| XOMA Ltd [Member] | |
| Option And License Agreement Description | clinical, regulatory and sales milestones for MNPR-101 that could reach up to $14.925 million if the Company achieves all milestones |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Details
|